Carregant...
Renoprotective effects of a selective estrogen receptor modulator, Raloxifene in an animal model of diabetic nephropathy
BACKGROUND/AIMS: Our previous studies have shown that supplementation with 17-β estradiol (E(2)) from the onset of diabetes attenuates diabetic nephropathy. But, E(2) is accompanied by feminizing effects as well as adverse side effects on other organs. The current study examined the renoprotective e...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2007
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3179626/ https://ncbi.nlm.nih.gov/pubmed/17308373 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000099837 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|